BOIRON Laboratories 2025 Financial Results

Boiron Laboratories has published its financial results for 2025. Revenue reached €501.1 million, marking a 2.8% increase compared to the previous year. At constant exchange rates, this increase was 4.1%, reaching €507.4 million. The results detail significant growth in North America of 14.4%, particularly in the United States, and a 20.4% increase in other markets such as Asia.

In terms of profitability, operating income increased by 177.5%, reaching €43.7 million. Net income, Group share, rose by 188% to €32.6 million. EBITDA amounted to €71.7 million, up 11.1%. The Board of Directors is proposing a dividend of €1.35 per share, with distribution scheduled for June 5, 2026.